143 related articles for article (PubMed ID: 34637340)
1. CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis.
Yang Y; Yuan G; Xie H; Wei T; Zhu D; Zhu Y; Zheng S
J Int Med Res; 2021 Oct; 49(10):3000605211013199. PubMed ID: 34637340
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NORAD accelerates the progression of non-small cell lung cancer via targeting miRNA-455/CDK14 axis.
Wang C; Wu D; He M; Guan L; Bai D; Liang B
Minerva Med; 2022 Oct; 113(5):817-824. PubMed ID: 33764714
[TBL] [Abstract][Full Text] [Related]
3. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of thyroid transcription factor-1 and HER2/neu in non-small cell lung cancer: strong thyroid transcription factor-1 expression predicts better survival.
Haque AK; Syed S; Lele SM; Freeman DH; Adegboyega PA
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):103-9. PubMed ID: 12051626
[TBL] [Abstract][Full Text] [Related]
5. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
[No Abstract] [Full Text] [Related]
6. Cyclin-dependent kinase 15 upregulation is correlated with poor prognosis for patients with breast cancer.
Zhang X; Wang Q; Luo Y; Song M; Zhou Z; Zeng L; Hu M; Yang C
J Int Med Res; 2021 Jun; 49(6):300060521999552. PubMed ID: 34162268
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
Li J; Wei L
Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
10. TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.
Zhang LX; Yang X; Wu ZB; Liao ZM; Wang DG; Chen SW; Lu F; Wu YB; Zhu SQ
Cancer Sci; 2023 Mar; 114(3):855-869. PubMed ID: 36403197
[TBL] [Abstract][Full Text] [Related]
11. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
Zhu B; Yan Y; Shao B; Tian L; Zhou W
J Int Med Res; 2018 Apr; 46(4):1517-1527. PubMed ID: 29363378
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues.
Zhu J; Li Q; He J; Ma K
Genet Mol Res; 2015 Nov; 14(4):14239-45. PubMed ID: 26600481
[TBL] [Abstract][Full Text] [Related]
14. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
15. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
[TBL] [Abstract][Full Text] [Related]
19. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
Zhang TM; Zhang J; Zhou DJ; Wang CL
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
[No Abstract] [Full Text] [Related]
20. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
Li J; Tu Y; Jiang L; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]